These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29531008)

  • 21. Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes.
    Elsabah H; Ghasoub R; Soliman DS; Ibrahim F; Aldapt MB; Taha RY; Al Azawi S; Mudawi D; Moustafa A; Elomri H; Cherif H
    Cancer Rep (Hoboken); 2024 Jul; 7(7):e2106. PubMed ID: 38967112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence.
    Dimopoulos MA; Papadimitriou C; Anagnostopoulos A; Mitsibounas D; Fermand JP
    Leuk Lymphoma; 2003 Jan; 44(1):153-5. PubMed ID: 12691157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.
    Kumar S; Pérez WS; Zhang MJ; Ballen K; Bashey A; To LB; Bredeson CN; Cairo MS; Elfenbein GJ; Freytes CO; Gale RP; Gibson J; Kyle RA; Lacy MQ; Lazarus HM; McCarthy PL; Milone GA; Moreb JS; Pavlovsky S; Reece DE; Vesole DH; Wiernik PH; Hari P
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1134-1140. PubMed ID: 18804043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose chemotherapy and allogenic peripheral blood stem cell transplantation for multiple myeloma evolving from intra-abdominal plasmacytoma.
    Chung KM; Chuang SS; Hwang WS; Lee PS; Li CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Nov; 65(11):557-60. PubMed ID: 12583522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
    Lee L; Alrasheed N; Khandelwal G; Fitzsimons E; Richards H; Wilson W; Chavda SJ; Henry J; Conde L; De Massy MR; Chin M; Galas-Filipowicz D; Herrero J; Chain B; Quezada SA; Yong K
    Front Immunol; 2021; 12():618610. PubMed ID: 33717112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission.
    Byrne JL; Fairbairn J; Davy B; Carter IG; Bessell EM; Russell NH
    Bone Marrow Transplant; 2003 Feb; 31(3):157-61. PubMed ID: 12621475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous stem cell transplantation in patients with high-risk plasmacytoma.
    Jantunen E; Koivunen E; Putkonen M; Siitonen T; Juvonen E; Nousiainen T
    Eur J Haematol; 2005 May; 74(5):402-6. PubMed ID: 15813914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
    Georges GE; Maris MB; Maloney DG; Sandmaier BM; Sorror ML; Shizuru JA; Lange T; Agura ED; Bruno B; McSweeney PA; Pulsipher MA; Chauncey TR; Mielcarek M; Storer BE; Storb R
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):423-32. PubMed ID: 17287157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High dose chemotherapy with autologous stem cell support in cancer patients].
    Abrahamsen JF; Kristoffersen EK; Hervig T; Ekanger R; Nesthus I; Ulvestad E
    Tidsskr Nor Laegeforen; 2000 May; 120(13):1523-8. PubMed ID: 10916472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
    Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
    Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple myeloma relapsed or progressed as plasmacytoma after allogeneic reduced-intensity stem cell transplantation: report of three cases].
    Sugimoto Y; Nishii K; Miyata E; Fujieda A; Yamaguchi M; Masuya M; Katayama N
    Rinsho Ketsueki; 2009 Apr; 50(4):289-94. PubMed ID: 19404022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
    Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
    Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-cerebral relapse following prolonged remission after autologous stem cell transplantation for multiple myeloma.
    Seftel MD; Maguire J; Voss N; Woodhurst WB; Dalal BI; Shepherd JD
    Leuk Lymphoma; 2002 Dec; 43(12):2399-403. PubMed ID: 12613531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of solitary plasmacytoma in the liver 10 years after the onset of multiple bone lesions.
    Numata J; Tsunemine H; Imai A; Nakamura N; Sakai T; Itoh T; Arima N
    J Clin Exp Hematop; 2024; 64(1):65-70. PubMed ID: 38538320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma].
    Fujii H; Iwai T; Ueda Y; Nakagawa H
    Rinsho Ketsueki; 2000 Dec; 41(12):1267-72. PubMed ID: 11201152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intensive treatment of multiple myeloma].
    Harousseau JL
    Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.